Personalized-support-header

PATIENT SUPPORT PROGRAM

quotes I like the Alongside™ program because it feels like talking to an old friend. They make me feel
cared for and less of a statistic. quotes

RACHEL W.

Switched to KESIMPTA® in 2020

Rachel W. has taken KESIMPTA and has been compensated for her time.

Individual results may vary.

Your Alongside Coordinator is
dedicated to you

With Alongside KESIMPTA, you'll be paired with a real person who can help you get started, answer questions, and provide helpful resources. 80% of people with commercial insurance get their first dose of KESIMPTA from the Alongside support program in 4 days or less.*

*Based on prescription data collected between April to September 2023.

ALONGSIDE KESIMPTA IS HERE TO HELP

Video: Real-Alongside-KESIMPTA-Coordinator 1650611526 1_dvmas78l

BECOME A MEMBER

Have a prescription,
but aren't a
member? Enroll in
Alongside KESIMPTA
and pay as little as
$0 co-pay.†

If you haven't heard from us yet,
enroll yourself below for personalized
support.

ENROLL NOW

GET HELP PAYING
FOR KESIMPTA

Whatever your situation,
Alongside KESIMPTA has options to help you save on KESIMPTA.

Journey-icon

We'll work on coverage in the background
with an insurance coverage review, and we'll
keep you in the loop on how it's going.

Access-Card-icon

Wondering about insurance? Eligible
patients with commercial insurance
get KESIMPTA for free while we work
with your health care provider to
secure coverage. Once covered, pay
as little as $0 co-pay.†

For those patients who may not have prescription drug coverage, the list price for KESIMPTA is $8,736 per treatment. The list
price may not reflect the price paid by patients; most patients with prescription coverage will pay less.

†Limitations apply. Offer not valid under Medicare, Medicaid, or any other federal or state health insurance program. Patients with commercial insurance coverage for KESIMPTA may receive up to $18,000 in annual co-pay benefits. Patients with commercial insurance and an initial denial of coverage may receive up to 12 months of free product while coverage is pursued. Novartis reserves the right to rescind, revoke, or amend this program without notice. See complete Terms & Conditions at start.kesimpta.com.

LEARN HOW TO TAKE KESIMPTA

Alongside KESIMPTA can help you take KESIMPTA with confidence.

With the KESIMPTA Sensoready® Pen, it typically takes less than 1 minute a month once you're ready to
inject,‡ and you can do it yourself at home or on the go.§

If you want a refresher on how to take KESIMPTA, we can walk you through it over video chat. We also have a Quick Tips for Use brochure and step-by-step videos if you'd like something to reference.

‡Typical administration time when ready to inject. Once monthly after 3 weekly starter doses.

§KESIMPTA Sensoready® Pens must be refrigerated at 2 °C to 8 °C (36 °F to 46 °F). Keep product in the original carton to protect from
light until the time of use. Do not freeze. To avoid foaming, do not shake.

Kesimpta-sensoready-pen-in-hand

YOUR COORDINATOR HELPS YOU GET STARTED

Leticia-image

quotes quotes I can help people with most anything they need to get started on KESIMPTA, from assisting with insurance questions to training on the Sensoready® Pen.  quotes quotes

- LETICIA, ALONGSIDE COORDINATOR

Dedicated support from a dedicated Alongside KESIMPTA Coordinator.

Coordinators obsess about the details so you don't have to. They'll also get to know you and answer any questions you may have. Once they help you get started, they'll stay in touch for 2 years. You can ask them about:

  • Paying for treatment

  • Delivery of KESIMPTA

  • Supplemental injection training and resources

  • Long-term support, like calls, texts, and emails

SEE WHAT PEOPLE ARE SAYING ABOUT ALONGSIDE KESIMPTA

Video: Alongside KESIMPTA 1650611588 1_px7domc7
jennifer image

quotes quotes My Alongside KESIMPTA Coordinator is there for me throughout my treatment...She is awesome!  quotes quotes

-JENNIFER B.

Jennifer B. has taken KESIMPTA and has been compensated for her time.

We'll call you once you're enrolled in Alongside KESIMPTA, but you can always
reach us here:
1-855-KESIMPTA (1-855-537-4678), 8:30 AM–8:00 PM ET, Monday–Friday.

1-855-KESIMPTA (1-855-537-4678),
8:30 AM–8:00 PM ET,
Monday–Friday.

Take a look at commonly asked questions.

GET SOME ANSWERS

Get the results of the head-to-head
studies vs AUBAGIO® (teriflunomide).

SEE THE RESULTS

Get the results of the head-to-head
studies vs AUBAGIO® (teriflunomide).

SEE THE RESULTS

Take a look at commonly asked questions.

GET SOME ANSWERS
email

Looking for help navigating life with RMS?

Let us bring you personalized resources.
Sign Up

email

Looking for help navigating
life with RMS?

Let us bring you
personalized resources.

Sign Up

phone

Prescribed KESIMPTA?
Pay as little as $0 co-pay† & enroll in the
Alongside™ KESIMPTA Support Program.

Enroll

phone

Prescribed KESIMPTA?
Pay as little as $0 co-pay† &
enroll in the Alongside™
KESIMPTA Support Program.

Enroll

RMS, relapsing multiple sclerosis.

+

-

IMPORTANT SAFETY INFORMATION

Who should not take KESIMPTA?

Do NOT take KESIMPTA if you:

  • have an active hepatitis B virus (HBV) infection.

  • have had an allergic reaction to ofatumumab or life-threatening

INDICATION

What is KESIMPTA (ofatumumab) injection?

KESIMPTA is a prescription medicine used to treat adults with relapsing forms of multiple sclerosis (MS)

KESIMPTA is a prescription medicine used to treat adults with relapsing forms of multiple

IMPORTANT SAFETY INFORMATION & INDICATION

INDICATION

What is KESIMPTA (ofatumumab) injection?

KESIMPTA is a prescription medicine used to treat adults with relapsing forms of multiple sclerosis (MS) including clinically isolated syndrome (CIS), relapsing-remitting disease, and active secondary progressive disease.

It is not known if KESIMPTA is safe or effective in children.

IMPORTANT SAFETY INFORMATION

Who should not take KESIMPTA?

Do NOT take KESIMPTA if you:

  • have an active hepatitis B virus (HBV) infection.

  • have had an allergic reaction to ofatumumab or life-threatening injection-related reaction to KESIMPTA.

What is the most important information I should know about KESIMPTA?

KESIMPTA can cause serious side effects such as:

  • Infections. Serious infections, which can be life-threatening or cause death, can happen during treatment with KESIMPTA. If you have an active infection, your health care provider (HCP) should delay your treatment with KESIMPTA until your infection is gone. KESIMPTA taken before or after other medicines that weaken the immune system may increase your risk of getting infections. Tell your HCP right away if you have any infections or get any symptoms including painful and frequent urination, nasal congestion, runny nose, sore throat, fever, chills, cough, or body aches.

INDICATION

What is KESIMPTA (ofatumumab) injection?

KESIMPTA is a prescription medicine used to treat adults with relapsing forms of multiple sclerosis (MS) including clinically isolated syndrome (CIS), relapsing-remitting disease, and active secondary progressive disease.

It is not known if KESIMPTA is safe or effective in children.

  • HBV reactivation. If you have ever had HBV infection, it may become active again during or after treatment with KESIMPTA (reactivation). If this happens, it may cause serious liver problems including liver failure or death. Before starting KESIMPTA, your HCP will do a blood test to check for HBV. They will also continue to monitor you during and after treatment with KESIMPTA for HBV. Tell your HCP right away if you get worsening tiredness or yellowing of your skin or the white part of your eyes.

  • Progressive Multifocal Leukoencephalopathy (PML). PML may happen with KESIMPTA. PML is a rare, serious brain infection caused by a virus that may get worse over days or weeks. PML can result in death or severe disability. Tell your HCP right away if you have any new or worsening neurologic signs or symptoms. These may include weakness on one side of your body, loss of coordination in arms and legs, vision problems, changes in thinking and memory, which may lead to confusion and personality changes.

  • Weakened immune system. KESIMPTA taken before or after other medicines that weaken the immune system could increase your risk of getting infections.

Before you take KESIMPTA, tell your HCP about all your medical conditions, including if you:

  • Have or think you have an infection including HBV or PML.

  • Have ever taken, currently take, or plan to take medicines that affect your immune system. These medicines could increase your risk of getting an infection.

  • Have had a recent vaccination or are scheduled to receive any vaccinations.

    • You should receive any required 'live' or 'live-attenuated' vaccines at least 4 weeks before you start treatment with KESIMPTA. You should not receive 'live' or 'live-attenuated' vaccines while you are being treated with KESIMPTA and until your HCP tells you that your immune system is no longer weakened.

    • Whenever possible, you should receive any 'non-live' vaccines at least 2 weeks before you start treatment with KESIMPTA.

    • Talk to your HCP about vaccinations for your baby if you used KESIMPTA during your pregnancy.

  • Are pregnant, think that you might be pregnant, or plan to become pregnant. It is not known if KESIMPTA will harm your unborn baby. Females who can become pregnant should use birth control (contraception) during treatment with KESIMPTA and for 6 months after your last treatment. Talk with your HCP about what birth control method is right for you during this time.

  • Are breastfeeding or plan to breastfeed. It is not known if KESIMPTA passes into your breast milk. Talk to your HCP about the best way to feed your baby if you take KESIMPTA.

Tell your HCP about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.

How should I use KESIMPTA?

See the detailed Instructions for Use that comes with KESIMPTA for information about how to prepare and inject a dose of KESIMPTA and how to properly throw away (dispose of) used KESIMPTA Sensoready pens or prefilled syringes.

  • Use KESIMPTA exactly as your HCP tells you to use it.

  • Your HCP will show you how to prepare and inject KESIMPTA the right way before you use it for the first time.

  • Do not inject into areas where the skin is tender, bruised, red, scaly or hard. Avoid areas with moles, scars, or stretch marks.

KESIMPTA may cause serious side effects including:

  • Injection-related reactions. Injection-related reactions are a common side effect of KESIMPTA. Injecting KESIMPTA can cause injection-related reactions that can happen within 24 hours (1 day) following the first injections and with later injections. There are two kinds of reactions:

    • at or near the injection site: redness of the skin, swelling, itching, and pain. Talk to your HCP if you have any of these signs and symptoms.

    • that may happen when certain substances are released in your body: fever, headache, pain in the muscles, chills, tiredness, rash, hives, trouble breathing, swelling of the face, eyelids, lips, mouth, tongue and throat, and feeling faint, or chest tightness. Contact your HCP right away if you experience any of these signs and symptoms, especially if they become worse or you have new severe signs of reactions after subsequent injections. It could be a sign of an allergic reaction, which can be serious.

  • Low immunoglobulins. KESIMPTA may cause a decrease in some types of antibodies. Your HCP will do blood tests to check your blood immunoglobulin levels.

The most common side effects of KESIMPTA include:

  • Upper respiratory tract infection, with symptoms such as sore throat and runny nose, and headache.

  • Headache.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

Please see full Prescribing Information including Medication Guide.

KESIMPTA, the KESIMPTA logo, and SENSOREADY are registered trademarks of Novartis AG.

ALONGSIDE and the ALONGSIDE logo are trademarks of Novartis AG.

AUBAGIO is a registered trademark of Genzyme, a Sanofi company.

Please see each product's respective PI for additional information including indication, dosing, and safety.